-transparent.png){kind=logo}
A study of the metabolism of [14C]-(+/-)-(R*)-2,6-dimethyl-4-(m-nitrophenyl)- 1,4-dihydropyridine-3, 5- dicarboxylic acid (R*)-1-benzyl-3-piperdidinyl ester, methyl ester hydrochloride (14C-benidipine hydrochloride, 14C-KW-3049) revealed as major metabolic pathways oxidative N-dealkylation, hydrolysis of the ester moiety, dehydrogenation of the 1,4-dihydropyridine ring, hydroxylation of the methyl group and decarboxylation in rat and dog. Rat and dog showed similar metabolic pathways, but some quantitative differences were found between rat and dog.
Related Publications
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
November 1988,
Arzneimittel-Forschung,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
November 1988,
Arzneimittel-Forschung,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
November 1988,
Arzneimittel-Forschung,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
July 1995,
Arzneimittel-Forschung,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
October 1978,
Toxicology and applied pharmacology,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
November 1988,
Arzneimittel-Forschung,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
November 1988,
Arzneimittel-Forschung,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
November 1988,
Arzneimittel-Forschung,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
June 2012,
The Journal of emergency medicine,
H Kobayashi, and
S Okumura, and
Y Kosaka, and
S Kobayashi, and
A Inoue, and
T Oka, and
N Nakamizo
November 1988,
Arzneimittel-Forschung,
